METHODS AND COMPOSITIONS FOR THE PREDICTION OF RESPONSE TO TRASTUZUMAB CONTAINING CHEMOTHERAPY REGIMEN IN MALIGNANT NEOPLASIA

• 1. 卵巢恶性肿瘤患者血栓风险预测模型建模方法及预测装置 [P] . 中国专利： CN113160980A . 2021-07-23
• 2. 一种评估预后和预测恶性疾病患者对免疫治疗的反应的方法 [P] . 中国专利： CN109715829A . 2019-05-03
• 3. METHODS AND COMPOSITIONS FOR THE PREDICTION OF RESPONSE TO TRASTUZUMAB CONTAINING CHEMOTHERAPY REGIMEN IN MALIGNANT NEOPLASIA [P] . 欧洲知识产权局专利： EP2064339A2 . 2009-06-03

  机译： 预测恶性肿瘤患者对包含曲妥珠单抗的化疗方案反应的方法和成分

• 4. Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia [P] . 美国专利： US2009280493A1 . 2009-11-12

  机译： 预测曲妥珠单抗含化学疗法对恶性肿瘤的反应的方法和成分

• 5. METHODS AND COMPOSITIONS FOR THE PREDICTION OF RESPONSE TO TRASTUZUMAB CONTAINING CHEMOTHERAPY REGIMEN IN MALIGNANT NEOPLASIA [P] . 世界知识产权组织专利： WO2008028926A2 . 2008-03-13

  机译： 预测恶性肿瘤患者对包含曲妥珠单抗的化疗方案反应的方法和成分

• 1. Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer [J] . Lu Yao, Juan Zhang, Yiqiang Liu, 中国癌症研究（英文版） . 2015,第006期
• 2. Effects of different chemotherapy regimens before radical operation for lung cancer on cancer cell growth and anti-tumor immune response [J] . Wei-Dong Liang, Peng Wu, Shi-Jun Liao, 海南医科大学学报（英文版） . 2018,第014期
• 3. Effects of different chemotherapy regimens before radical operation for lung cancer on cancer cell growth and anti-tumor immune response [J] . Wei-Dong Liang, Peng Wu, Shi-Jun Liao, 海南医科大学学报(英文版) . 2018,第014期
• 4. A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG [C] . KIMBERLY R. KANIGEL WINNER, JAMES C. COSTELLO Pacific Symposium on Biocomputing . 2017
• 5. Combining biomarkers and clinicopathologic factors for prediction of response to adjuvant chemotherapy for breast cancer: Cox model and Support Vector Machine (SVM) methods. [D] . Liu, Xudong. 2010
• 6. Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report [O] . Jun Wang, George W Saukel, Carlos A Garberoglio, 2010
• 7. Pathological Complete Response after Preoperative Chemotherapy with a Regimen Containing Trastuzumab in Esophagogastric Junction Adenocarcinoma: A Case Report [O] . Keisuke Arai, Shingo Kanaji, Daiki Okamoto, 2016

• 1. Trastuzumab Re-Introduction with FOLFIRI for Treatment of HER2 Overexpression-Advanced Gastric Adenocarcinoma Following Failure of Other Trastuzumab-Based Chemotherapy Regimens [J] . Olivier Dubreuil ,Aziz Zaanan ,Olivier Pellerin . 临床医学病理报告（英文） . 2015,第4期
• 2. Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report [J] . Qi Jiang ,Mi-Xue Xie ,Xiao-Chen Zhang . 世界临床病例杂志 . 2020,第003期
• 3. 恶性肿瘤患者知情状况及其对心理行为反应和治疗护理依从性反应的影响 [C] . 牛瑞霞 ,武永忠 ,许凡 . 第四届全国肿瘤诊疗新进展及新技术学术会议 . 2009
• 4. HER-2阳性乳腺癌新辅助含曲妥珠单抗化疗方案的临床研究 [A] . 王硕 . 2020